|
PF-53730 |
DUAKLIR GENUAIR 340 mcg/12 mcg Polvo para inhalación |
2022-01-18 |
|
Astrazeneca AB |
España
|
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
Agencias J.I. Cohen |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-53966 |
EKLIRA GENUAIR 322 ug Polvo para inhalación |
2022-05-09 |
|
Astrazeneca AB |
España
|
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
Agencias J.I. Cohen |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-37800 |
BLOKIUM 50 mg Comprimidos |
2026-10-08 |
|
Almirall, S.A. |
España
|
Leterago |
Amicelco |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-37799 |
BLOKIUM-DIU Comprimidos |
2026-08-31 |
|
Almirall, S.A. |
España
|
Leterago |
Amicelco |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-37805 |
BLOKIUM 100 mg Comprimidos |
2026-08-31 |
|
Almirall, S.A. |
España
|
Leterago |
Amicelco |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-37815 |
SEKISAN 3.54 mg/mL Jarabe |
2026-10-12 |
|
Almirall, S.A. |
España
|
Leterago |
Amicelco |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-38052 |
AIRTAL 100 mg Comprimidos recubiertos con película |
2027-03-25 |
|
Almirall, S.A. |
España
|
Leterago |
Amicelco |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-12043 |
Carbamacepina IQSA 200 mg tabletas |
2007-11-02 |
|
Industrias Quimicas S.A. De C.V. |
El Salvador
|
Agefinsa (Agencia Farm. Intern., S.A.) |
Americana S.A. |
Medicin Farmaceutica S.A. |
Productos Medico-farmaceutico S.A. Promefasa |
Refasa S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-7798 |
Tantum rosa solución vaginal |
2007-10-09 |
|
Industrias Quimicas S.A. De C.V. |
El Salvador
|
Agefinsa (Agencia Farm. Intern., S.A.) |
Americana S.A. |
Medicin Farmaceutica S.A. |
Productos Medico-farmaceutico S.A. Promefasa |
Refasa S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-12042 |
Agua Destilada USP IQSA para uso parenteral |
2007-11-02 |
|
Industrias Quimicas S.A. De C.V. |
El Salvador
|
Agefinsa (Agencia Farm. Intern., S.A.) |
Americana S.A. |
Medicin Farmaceutica S.A. |
Productos Medico-farmaceutico S.A. Promefasa |
Refasa S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|